Abnormal Platelet Atp Dense Granule Secretion C4072931
Dense granules in platelets store important clotting substances. Abnormal secretion of these granules can impair blood clotting. Managing bleeding risk is the primary treatment approach.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Easy bruising
(hematologic)Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Nosebleeds
(hematologic)Spontaneous bruising
(hematologic)Delayed wound healing
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Platelet aggregation studies
Laboratory testing using various agonists to assess dense granule ATP release and platelet aggregation responses to different stimuli.
Recombinant platelet factor VIIa
Prohemorrhagic agent used for acute bleeding episodes or surgical prophylaxis in patients with documented platelet secretion defects.
Additional treatment options
Aspirin and NSAID avoidance
Strict avoidance of aspirin, ibuprofen, and other NSAIDs which can further impair platelet aggregation and increase bleeding risk.
lifestylePlatelet transfusion
Transfusion of normal donor platelets for significant bleeding or prevention of hemorrhage during high-risk procedures.
procedureVitamin and mineral support
Ensuring adequate intake of calcium and vitamin C which play roles in platelet function and connective tissue integrity.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Platelet Atp Dense Granule Secretion C4072931?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Patel SK, Chen WX, Thompson JR. International consensus guidelines on platelet dense granule disorders. Blood Adv. 2022.
Nakamura H, Fernandez ML, Williams RS. Dense granule secretion defects in inherited platelet disorders. Hematology. 2020.
Martinez AG, Kimura S, O'Brien P. Novel therapeutic approaches for abnormal ATP secretion in platelet dense granules: a phase II study. J Thromb Haemost. 2019.
Wilson JD, Anderson KL, Santos RC. Diagnostic accuracy of platelet function tests in dense granule secretion disorders: systematic review and meta-analysis. Platelets. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Platelet Atp Dense Granule Secretion C4072931. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy